Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  939 نتائج ل ""Sodium-Glucose Transporter 2 Inhibitors""

فلترة النتائج

Subject : diabetes mellitus
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Age-dependent effects of SGLT2 inhibitors on stroke risk in geriatric patients with diabetes and atrial fibrillation.

  • Authors : Chua SK; School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, 24205, Taiwan, ROC.; Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei City, Taiwan, ROC.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/diagnosis ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/epidemiology ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Jan 22; Vol. 24 (1), pp. 27. Date of Electronic Publication: 2025 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies.

  • Authors : Karakasis P; Second Department of Cardiology, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54124 Thessaloniki, Greece.; Theofilis P

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/etiology ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Feb 28; Vol. 26 (5). Date of Electronic Publication: 2025 Feb 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The short-term follow-up of patients with diabetes mellitus presenting with COVID-19.

  • Authors : Lespezeanu DA; Ion Pavel Diabetes Center, Prof. Dr. N. C. Paulescu National Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania.; Doctoral School, Titu Maiorescu University of Bucharest, Romania.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; Blood Glucose*/Blood Glucose*/Blood Glucose*/metabolism

  • Source: Journal of medicine and life [J Med Life] 2025 Feb; Vol. 18 (2), pp. 116-124.Publisher:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of SGLT2 inhibitors on cardiovascular events in patients with atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.

  • Authors : Zheng S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; Lai Y

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2024 Jan; Vol. 47 (1), pp. 58-65. Date of Electronic Publication: 2023 Nov 27.Publisher: Futura Pub. Co. Country of Publication: United States NLM ID: 7803944 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment of diabetic kidney disease. A network meta-analysis.

  • Authors : Büttner F; Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.; Barbosa CV

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Kidney Failure, Chronic*/Kidney Failure, Chronic*/Kidney Failure, Chronic*/drug therapy

  • Source: PloS one [PLoS One] 2023 Nov 02; Vol. 18 (11), pp. e0293183. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Editorial & Opinion

Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin.

  • Authors : Rhee SY; Department of Endocrinology and Metabolism, College of Medicine, Kyung Hee University, Seoul, Korea.; Center for Digital Health, Kyung Hee University, Seoul, Korea.

Subjects: Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use; Humans

  • Source: Diabetes & metabolism journal [Diabetes Metab J] 2023 Nov; Vol. 47 (6), pp. 769-770. Date of Electronic Publication: 2023 Nov 24.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Sex and age differences in the use of medications for diabetes and cardiovascular risk factors among 25,733 people with diabetes.

  • Authors : Lee CMY; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; School of Population Health, Curtin University, Perth, Western Australia, Australia.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/drug therapy

  • Source: PloS one [PLoS One] 2023 Oct 24; Vol. 18 (10), pp. e0287599. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Impact of sodium-glucose co-transporter 2 inhibitors on renal outcomes in patients of diabetes mellitus: A meta-analysis of landmark renal and cardiovascular outcome trials.

  • Authors : Bose D; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.; Maurya M

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus* ; Symporters*

  • Source: Indian journal of pharmacology [Indian J Pharmacol] 2023 Mar-Apr; Vol. 55 (2), pp. 119-127.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.

  • Authors : Lee K; College of Medicine, Ewha Womans University, Seoul, Republic of Korea.; Lee SK

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: PloS one [PLoS One] 2023 Jan 18; Vol. 18 (1), pp. e0280359. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Gliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In Vitro.

  • Authors : Koch B; Department of Internal Medicine 4, Nephrology, University Hospital, Goethe-University, 60596 Frankfurt, Germany.; Fuhrmann DC

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 17; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  939 نتائج ل ""Sodium-Glucose Transporter 2 Inhibitors""